SCHEMBL15630201

SCHEMBL15630201

COc1ccc(Br)cc1-c1oc2c(ccc3ccccc32)c(=O)c1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 10/20 0.69
ABCB1 P08183 3/20 0.69
ABCC1 P33527 4/20 0.55
KDM4E B2RXH2 3/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MEN1 O00255 2/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP3A4 P08684 2/20 0.49
HPGD P15428 2/20 0.49
KMT2A Q03164 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CSNK2A2 P19784 2/20 0.47
CSNK2B P67870 2/20 0.47
CSNK2A1 P68400 2/20 0.47
CYP1A1 P04798 3/20 0.47
CYP1A2 P05177 3/20 0.47
CYP1B1 Q16678 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15619432 0.82 KDM4E (0.76) ABCG2ABCB1KDM4EALOX15TSHR
SCHEMBL14697214 0.79 ABCG2 (0.85) ABCG2ABCB1ABCC1KDM4EALOX15
SCHEMBL14697207 0.74 ABCG2 (0.79) ABCG2ABCB1ABCC1KDM4EMEN1
SCHEMBL14708630 0.74 ABCG2 (0.79) ABCG2ABCB1ABCC1KDM4EMEN1
SCHEMBL15619755 0.73 KDM4E (0.55) ABCG2KDM4EALOX15TSHRHTT
SCHEMBL17292888 0.73 ABCG2 (1.00) ABCG2ABCB1ABCC1KDM4EALOX15
SCHEMBL14697069 0.72 ABCG2 (0.74) ABCG2ABCB1ABCC1KDM4EMEN1
SCHEMBL14697050 0.72 ABCG2 (0.73) ABCG2ABCB1ABCC1KDM4EMEN1
SCHEMBL14697044 0.71 ABCG2 (0.69) ABCG2ABCB1ABCC1KDM4EALOX15
SCHEMBL15619440 0.70 TP53 (0.68) ABCB1KDM4EALOX15TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9629822-B2 Flavonoid based antiviral targets UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-04-25 US disclosed
US-9629822-B2 Flavonoid based antiviral targets UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-04-25 US disclosed
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, (US) 2015-07-30 US disclosed
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, (US) 2015-07-30 US disclosed
WO-2014047551-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTER FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS RBM28, MAVS, HAVCR2 ABCG2 3045/4885ABCB1 3430/4885ABCC1 3458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.